Insomnia drug comparisons changed after accounting for follow-up and age
Adjusted analyses made some sleep benefits less certain; adverse-event reports provided a separate set of safety signals.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Several insomnia medicines showed favourable results for time spent awake after initially falling asleep compared with placebo. However, some conclusions changed when the analysis accounted for follow-up duration or age. Safety signals came from a separate adverse-event reporting database, which cannot establish how often these events occur among all people using a medicine.
This abstract-based explanation cannot assess the full trial methods or adverse-event reporting patterns. The abstract omits overall trial durations, and the authors call for more direct comparisons between medicines.
What researchers found
Time awake after sleep onset with melatonin 6 mg/d
Versus placebo; the standardized effect's confidence interval included no difference. Overall trial timeframes were not reported.
Why adjustment matters
The melatonin comparison illustrates why adjustment matters. Its initial advantage for time awake after falling asleep was no longer statistically clear after accounting for follow-up duration; this does not prove there was no effect.
How to read safety signals
Safety findings came from reports submitted to an adverse-event database. Differences in reporting are signals for further investigation; they do not establish that a drug caused an event or quantify its absolute risk.
The original publication
Efficacy and safety of insomnia pharmacotherapies: Convergent evidence from Bayesian network meta-regression and FAERS-based disproportionality analysis.
Liu H, Wang Y, Li M et al.
Sleep Med · 2025
- PubMed ID
- 41101148
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.